Abbreviated MRI for HCC Surveillance
- Conditions
- Chronic HepatitisHepatocellular CarcinomaLiver Cirrhosis
- Interventions
- Diagnostic Test: Biannual ultrasonographyDiagnostic Test: Annual abbreviated liver MRI
- Registration Number
- NCT03731923
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This study aims to investigate the clinical feasibility of abbreviated liver MRI for HCC surveillance in a high-risk group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 257
- high risk of HCC development (chronic hepatitis B, chronic hepatitis C, liver cirrhosis)
- no history of HCC
- on surveillance of HCC using ultrasonography
- sign informed consent
- history of HCC
- congestive hepatopathy
- iron deposition
- any absolute or relative contra-indication of contrast-enhanced MRI
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description High risk group of HCC Biannual ultrasonography High risk group of HCC with chronic hepatitis or liver cirrhosis. Participants undergo biannual ultrasonography and annual abbreviated liver MRI. High risk group of HCC Annual abbreviated liver MRI High risk group of HCC with chronic hepatitis or liver cirrhosis. Participants undergo biannual ultrasonography and annual abbreviated liver MRI.
- Primary Outcome Measures
Name Time Method Sensitivity for detecting HCC 12 months after last MRI Sensitivity for detecting HCC
- Secondary Outcome Measures
Name Time Method Specificity for detecting HCC 12 months after last MRI Specificity for detecting HCC
Table time of abbreviated MRI 1 day after each MRI time from scan start and scan end
Image quality of abbreviated liver MRI 12 months after last MRI qualitative analysis on four-point scale
In-room time of abbreviated MRI 1 day after each MRI interval between participants' walk-in and walk-out times
Sensitivity for detecting early stage HCC 12 months after last MRI Sensitivity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)
Specificity for detecting early stage HCC 12 months after last MRI Specificity for detecting early stage HCC (≤3cm, ≤3 tumors, or ≤5cm single tumor)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
The Catholic University of Korea, Seoul St. Mary's Hospital
🇰🇷Seoul, Korea, Republic of
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of